Trial Profile
Brain stimulator and levodopa infusion impact on quality of life and functioning of the autonomic nervous system in Parkinson's disease patients [Aivo stimulaattorin ja levodopa infuusion vaikutus elämänlaatuun ja autonomisen hermoston toimintaan Parkinsonin tautia sairastavilla potilailla].
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2014
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 20 Sep 2014 Status changed from recruiting to completed, as per European Clinical Trials Database record.
- 29 Mar 2012 Planned End Date changed to 10 Sep 2014.
- 18 Jul 2011 New trial record